Tony Makhlouf, MD
NPI 1992932214 · Rheumatology Physician · Simi Valley, CA
Enrolled with Medicare as Practitioner - Hospitalist · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1992932214
- Entity type
- Individual
- Primary specialty
- Rheumatology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- No
- License
- A127473 (CA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
17 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
2 documented practice locations
- Medicare service volume (vs. specialty peers)25% of score
5,060 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Administration of Non-Hormonal Anti-Neoplastic Chemotherapy Under Skin Or Into Muscle96401 | 1,764 | $82 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 1,629 | $137 |
| Administration of Chemotherapy Into Vein, 1 Hour Or Less96413 | 560 | $148 |
| Administration of Chemotherapy Into Vein, Each Additional Hour96415 | 280 | $31 |
| Injection of Additional New Drug Or Substance Into Vein96375 | 188 | $17 |
| New Patient Office Or Other Outpatient Visit With Moderate Level of Medical Decision Making, If Using Time, 45 Minutes Or More99204 | 166 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 44 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Hydroxychloroquine Sulfate | 490 | 111 |
| Methotrexate Sodiumbrand: Methotrexate | 448 | 107 |
| Methylprednisolone | 177 | 120 |
| Prednisone | 161 | 55 |
| Tizanidine Hcl | 145 | 48 |
| Hydrocodone/Acetaminophenbrand: Hydrocodone-Acetaminophen | 106 | 21 |
| Alendronate Sodium |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$3,354 across 174 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Additional practice locations (1)
- 2100 Solar DrOxnard, CA 93036-2661Phone: (805) 842-1793Fax: (866) 624-1228
Registry dates
- Enumerated
- 2009-06-12
- Last updated
- 2024-06-28
- Certified
- 2024-06-28
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.